Featuring perspectives from Dr Christopher Flowers, Dr Manali Kamdar, Ms Robin Klebig and Ms Caitlin Murphy, including the following topics:
- Introduction: Overview of Bispecific Antibodies and Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma (0:00)
- Current and Future Use of Bruton Tyrosine Kinase Inhibitors for Mantle Cell Lymphoma (16:09)
- First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL) (40:03)
- Role of Loncastuximab Tesirine for Patients with Relapsed/Refractory (R/R) DLBCL (57:31)
- Role of Tafasitamab for Patients with R/R DLBCL and Follicular Lymphoma (1:16:59)
NCPD information and select publications
Research To Practice | Oncology Videos